Neoplasms, Hormone-Dependent
4 clinical trials · Condition
◉ Watch Neoplasms, Hormone-Dependent
| Record | Firm | Date |
|---|---|---|
| An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer (NCT00748358) | Assistance Publique - Hôpitaux de Paris | 2008-03-01 |
| Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer (NCT00267553) | Intarcia Therapeutics | 2005-11-01 |
| The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer (NCT00097344) | Intarcia Therapeutics | 2004-12-01 |
| Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer (NCT00044291) | Intarcia Therapeutics | 2002-06-01 |
Track Neoplasms, Hormone-Dependent automatically
Every clearance here is in the API, with alerts when new ones post.